1. Antidepressant use associated with youth suicide?

   News item 02 January 2021 Pages: 1 - 1

2. Antivirals including protease inhibitors linked with worse liver outcomes

   News item 02 January 2021 Pages: 2 - 2

3. Carboplatin: risk of posterior reversible encephalopathy syndrome

   News item 02 January 2021 Pages: 3 - 3

4. ELMIRON: risk of pigmentary maculopathy

   News item 02 January 2021 Pages: 4 - 4

5. Managing allergic reactions to Pfizer-BioNTech COVID-19 vaccine

   News item 02 January 2021 Pages: 5 - 5

6. Medsafe reviewing risk/benefit of bufexamac/chlorhexidine/lidocaine

   News item 02 January 2021 Pages: 6 - 6

7. Medsafe update on fluoxetine-levothyroxine drug interaction

   Unknown 02 January 2021 Pages: 7 - 7

8. Medsafe: oral fluconazole may increase spontaneous abortion risk

   News item 02 January 2021 Pages: 8 - 8

9. PMDA revises precautions and package inserts for five therapeutics

   News item 02 January 2021 Pages: 9 - 9

10. Sibutramine-induced AEs due to adulterated products

    News item 02 January 2021 Pages: 10 - 10

11. Remdesivir use in severe renal impairment: benefits outweigh risks

    Clinical study 02 January 2021 Pages: 11 - 11

12. Other adverse reaction research

    News item 02 January 2021 Pages: 12 - 12

13. Lactobacillus-rhamnosus

    Case report 02 January 2021 Pages: 13 - 13

14. Abatacept/prednisolone/vonoprazan

    Case report 02 January 2021 Pages: 14 - 14

15. Abiraterone

    Case report 02 January 2021 Pages: 15 - 15

16. Acetylcysteine

    Case report 02 January 2021 Pages: 16 - 16

17. Acetylcysteine

    Case report 02 January 2021 Pages: 17 - 17

18. Acetylcysteine/cyclophosphamide/ursodeoxycholic acid

    Case report 02 January 2021 Pages: 18 - 18

19. Acetylcysteine/steroids

    Case report 02 January 2021 Pages: 19 - 19

20. Adalimumab

    Case report 02 January 2021 Pages: 20 - 20

21. Adalimumab

    Case report 02 January 2021 Pages: 21 - 21

22. Adalimumab

    Case report 02 January 2021 Pages: 22 - 22

23. Adalimumab

    Case report 02 January 2021 Pages: 23 - 23

24. Adalimumab

    Case report 02 January 2021 Pages: 24 - 24

25. Adalimumab

    Case report 02 January 2021 Pages: 25 - 25

26. Adalimumab

    Case report 02 January 2021 Pages: 26 - 26

27. Adalimumab

    Case report 02 January 2021 Pages: 27 - 27

28. Adalimumab/methotrexate/prednisone

    Case report 02 January 2021 Pages: 28 - 28

29. Adalimumab/prednisone

    Case report 02 January 2021 Pages: 29 - 29

30. Afatinib

    Case report 02 January 2021 Pages: 30 - 30

31. Albendazole

    Case report 02 January 2021 Pages: 31 - 31

32. Albendazole/ivermectin/immunosuppressants

    Case report 02 January 2021 Pages: 32 - 32

33. Alcohol/doxorubicin

    Case report 02 January 2021 Pages: 33 - 33

34. Alectinib/crizotinib

    Case report 02 January 2021 Pages: 34 - 34

35. Alemtuzumab

    Case report 02 January 2021 Pages: 35 - 35

36. Alemtuzumab

    Case report 02 January 2021 Pages: 36 - 36

37. Alendronic acid

    Case report 02 January 2021 Pages: 37 - 37

38. Alendronic acid/ibandronic acid

    Case report 02 January 2021 Pages: 38 - 38

39. Alendronic-acid

    Case report 02 January 2021 Pages: 39 - 39

40. Alirocumab/atorvastatin

    Case report 02 January 2021 Pages: 40 - 40

41. Allopurinol

    Case report 02 January 2021 Pages: 41 - 41

42. Aloe vera

    Case report 02 January 2021 Pages: 42 - 42

43. Alprazolam/baclofen

    Case report 02 January 2021 Pages: 43 - 43

44. Alteplase/lisinopril

    Case report 02 January 2021 Pages: 44 - 44

45. Amfetamine/misoprostol interaction

    Case report 02 January 2021 Pages: 45 - 45

46. Amikacin/cotrimoxazole

    Case report 02 January 2021 Pages: 46 - 46

47. Aminocaproic acid/bevacizumab/tranexamic acid

    Case report 02 January 2021 Pages: 47 - 47

48. Amiodarone

    Case report 02 January 2021 Pages: 48 - 48

49. Amiodarone

    Case report 02 January 2021 Pages: 49 - 49

50. Amiodarone/bisoprolol

    Case report 02 January 2021 Pages: 50 - 50